IS CCIV STOCK A BUY? & WHAT IS GOING ON WITH THE NIO STOCK PRICE PREDICTION - Stock Market Crash?

TL;DR

Stockmo discusses the performance of CCIV and NIO in his portfolio, as well as new stock picks including ARKG and Hyzon, highlighting the potential for growth and diversification in his portfolio.

Transcript

hi everyone stock mo here and tesla cat making his appearance today's video is for entertainment purposes only but we're here to discuss all the good things out there that are happening the cciv is popping but of course neo is dropping so it is a little bit of a mixed day but i wanted to talk about the two newest stocks that i just added in my port... Read More

Key Insights

• 🥺 Stockmo's YouTube portfolio has performed well, with CCIV leading the pack and NIO also showing strong growth.
• 👶 Stockmo values diversification and has incorporated new stock picks like ARKG and Hyzon to broaden his portfolio's exposure.
• 👶 The penny stock portfolio has experienced losses due to market volatility, prompting Stockmo to potentially reevaluate and add new penny stocks.

Questions & Answers

Q: What is the performance of CCIV in Stockmo's portfolio?

CCIV has seen a remarkable increase of almost 92% in Stockmo's YouTube portfolio, making it one of his best-performing stocks.

Q: What is Stockmo's strategy for penny stocks in the portfolio?

Stockmo sets a limit of a 10-15% loss for penny stocks and considers moving them into different positions if they meet this threshold.

Q: What are the new stock picks discussed by Stockmo?

Stockmo shares his recent stock picks, including ARKG for its presence in the genomic space and potential revenue growth, and Hyzon for its involvement in the hydrogen fuel industry.

Q: What is Stockmo's outlook on NIO?

Stockmo remains optimistic about NIO, despite short-term volatility, believing in its long-term potential and referring to its previous price fluctuations as normal for growth stocks.

Summary & Key Takeaways

• Stockmo's YouTube portfolio is up 4.49% despite a red market, with CCIV performing exceptionally well, up almost 92%.

• The penny stock portfolio has taken a hit due to the volatile market but Stockmo is considering reevaluating and potentially adding new penny stocks to the portfolio.

• Stockmo shares his recent stock picks, including ARKG for its potential in the genomic space and Hyzon for its involvement in the hydrogen fuel industry.